Vitamin C activity of dehydroascorbic acid in humans--association between changes in the blood vitamin C concentration or urinary excretion after oral loading.

We performed oral loading of AsA or DAsA (1 mmol) in subjects who had consumed a diet low in vitamin C (C) (C< or =5 mg/d) for 3 d before loading, and measured urinary and blood vitamin C. Since the crossover method was used, the same experiment was repeated after an interval of about 1 mo in each subject. The results of the experiment including a total of 17 subjects for 2005 and 2006, were as follows. (1) There were marked individual differences in urinary C excretion. (2) The C level in 24-h urine after C loading did not differ between the two orally administered C forms (AsA and DAsA). (3) C excretion between 0 and 3 h after C loading was significantly higher (p<0.05) for the DAsA group, while those between 3 and 6, 6 and 9, 9 and 12, and 12 and 24 h after C loading were significantly higher (p<0.05 or p<0.01) for the AsA group. (4) The blood C concentration and the increase in C 1 h after C loading were significantly higher (p<0.05 and p<0.01, respectively) in the DAsA than in the AsA group. (5) Evaluation of the association between C metabolism and the single nucleotide polymorphisms of glutathione S-transferase P (GSTP) 1-1 showed a lower urinary C excretion and a significantly lower C level in 24-h urine (p<0.05) after AsA loading, and a significantly lower urinary C excretion between 0 and 3 h after DAsA loading (p<0.05) for the GA heterozygotes than for the AA homozygotes. Considering the activity of C as DAsA in humans, based on urinary and blood C levels after a single loading of C, the utilization of DAsA is equivalent to that of AsA, although the metabolic turnover time is different. The involvement of polymorphisms in the xenobiotic metabolizing enzyme, GSTP1-1, in C metabolism, particularly urinary C excretion, was also clarified. This demonstrates the necessity of considering gene polymorphisms in determining individual C requirements. An abstract of this paper was reported by the Vitamin C Research Committee (Ochanomizu University) in 2007.

Genetic polymorphisms of xenobiotic enzymes affect human vitamin C excretion.

This study describes the effect of gene polymorphisms on the metabolism of vitamin C. An oral loading of 1 mmol ascorbic acid (176 mg) or dehydroascorbic (174 mg) was given to 17 healthy females volunteers who had consumed a low vitamin C diet (vitamin C < 5 mg/day) for 3 days before loading. The urinary total vitamin C was determined. The urinary excretion of vitamin C (VC) was compared between ascorbic acid (AsA) and dehydroascorbic acid (DAsA), and the 24 hour total VC excretion was same. However gene polymorphisms of glutathione S-transferases P1 (GSTP1) showed the effect on that excretion. GSTP1 is one of xenobiotic enzymes in VC metabolism. The VC excretions in 24 hour after VC loading were greater (P < .01) in AA homozygotes of GSTP1 (46.7 +/- 18.1 mg) than GA heterozygotes (28.2 +/- 14.0 mg). On the single oral administration, the type of polymorphisms of GSTP1 has stronger effect on VC metabolism than the form of VC, DAsA and AsA. This study showed that determination of nutrient requirement needs to be considered with personal genotype.

Polymorphism of glutathione S-transferase P1 gene affects human vitamin C metabolism.

There are large inter-individual differences in the metabolism of vitamin C (VC), which is composed of both ascorbic acid (AsA) and dehydroascorbic acid (DAsA). AsA is oxidized to DAsA in a series of xenobiotic reactions. Thus, the effects of polymorphism A313G (Ile105Val) in the gene for glutathione S-transferases P1 (GSTP1), one of the most active xenobiotic enzymes, on human VC metabolism were studied. The variant frequency of GSTP1 among the present subjects (n=210) was AA 71.0%; GA 27.0% and GG 1.9%. At 24 h after administration of 1 mmol of VC to young women (n=17; age, 21.0+/-1.1 y), total VC excretion (46.7+/-18.1mg) by AA homozygotes of GSTP1 was greater (p<0.0069) than that (28.2+/-14.0 mg) by GA heterozygotes. One hour after administration of VC, blood total VC levels were also significantly different (p<0.0036) between the homozygotes and heterozygotes. The effects of other polymorphisms in xenobiotic enzymes on VC metabolism were small.